Edward J. Miller, MD, PhD
Director, Nuclear Cardiology
Yale School of Medicine

Disclosures: Research Grants: Alnylam, Eidos, Pfizer; Consultant: Alynlam, Roivant, Eidos, Pfizer

After participating in this activity, learners should be able to achieve the following:

• Understand the optimal patient preparation for FDG-PET imaging for Cardiac Sarcoidosis
• Describe the various methodologies for interpreting FDG-PET for CS
• Discuss the use of FDG-PET for diagnosis, prognosis, and response to treatment of CS